NCT03552146 - Evaluating the Effects of Propofol vs. Dexmedetomidine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions

Sedative Adverse Reaction

Interventions

DRUG

Propofol

Patients will be randomized to either propofol or dexmedetomidine and then observed for sedation-related events from time of drug administration to discharge.

DRUG

Dexmedetomidine

Patients will be randomized to either propofol or dexmedetomidine and then observed for sedation-related events from time of drug administration to discharge.

Trial Locations (1)

30342

RECRUITING

Children's Healthcare of Atlanta, Atlanta